Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Uherské Hradiště
Clinical trial register · Czechia

Clinical Trials in Uherské Hradiště, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Czechia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1513 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:18 UTC
1513
Studies in scope
all four open statuses
780
Recruiting now
open to new participants
300
Lead sponsors
across recruiting studies
Top sites
Prague 1080 Brno 610 Hradec Králové 323 Olomouc 313 Ostrava 282
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Novartis Pharmaceuticals7 Janssen Research & Development, LLC7 Eli Lilly and Company6 AbbVie3 Ascletis Pharma (China) Co., Limited2 Bristol-Myers Squibb2 Takeda2 AstraZeneca1 EMD Serono Research & Development Institute, Inc.1 Immunovant Sciences GmbH1 Sanofi1 Spyre Therapeutics, Inc.1 Novo Nordisk A/S1 Boehringer Ingelheim1 UCB Biopharma SRL1 Alfasigma S.p.A.1
Site location
Prague1080 Brno610 Hradec Králové323 Olomouc313 Ostrava282 Pilsen117 Pardubice92 České Budějovice61 Zlín47 Nový Jičín45 Uherské Hradiště38 Liberec36 Náchod33 Ústí nad Labem33 Ostrava - Poruba32 Ostrava-Poruba32 Brandýs nad Labem30 Jihlava29 Teplice26 Hořovice24 Slaný17 Hodonín16 Kladno15 Hlučín14 Choceň14 Show all 215
All 215 locations
Target enrolment
to

Trials with a site in Uherské Hradiště

38 of 1513 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Czechia
Start
Recruiting
Ascletis Pharma (China) Co., Limited
Phase 3
3,003
Pardubice, Prague, Uherské Hradiště
2026-08-31
Recruiting
Ascletis Pharma (China) Co., Limited
Phase 3
1,560
Pardubice, Prague, Uherské Hradiště
2026-08-28
Recruiting
Eli Lilly and Company
Phase 3
2,001
Brno, České Budějovice, Habry, Ostrava, Prague, Praha 9 - Klanovice, Uherské Hradiště
2026-08-26
Recruiting
Sanofi
Phase 3
300
Hlučín, Ostrava, Prague, Uherské Hradiště, Zlín
2026-05-12
Recruiting
EMD Serono Research & Development Institute, Inc.
Phase 3
202
Brno, Prague, Uherské Hradiště
2026-04-01
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe
DrugZotemtegrast
Eli Lilly and Company
Phase 2
1,431
Hradec Králové, Pardubice, Prague, Slaný, Sternberk, Uherské Hradiště, Vsetín
2026-03-26
Recruiting
Takeda
Phase 3
1,182
Ostrava, Pardubice, Prague, Uherské Hradiště, Zlín
2026-03-11
Recruiting
Eli Lilly and Company
Phase 3
900
Brno, Ostrava, Pardubice, Uherské Hradiště
2026-02-09
Active, closed
Janssen Research & Development, LLC
Phase 2
157
Břeclav, Hlučín, Karvina Frystat, Pardubice, Prague, Uherské Hradiště
2026-01-15
Recruiting
UCB Biopharma SRL
Phase 1
392
Brno, Hlučín, Ostrava, Uherské Hradiště
2025-12-10
Recruiting
Novo Nordisk A/S
Phase 3
1,280
Broumov, Brno, Olomouc, Ostrava-Poruba, Prague, Uherské Hradiště
2025-10-02
Active, closed
A Study of SPY072 in Rheumatic Disease
NCT07148414Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, Rheumatic Diseases
DrugSPY072
Spyre Therapeutics, Inc.
Phase 2
285
Hlučín, Moravská Ostrava, Pardubice, Prague, Uherské Hradiště
2025-08-21
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Brandýs nad Labem, Brno, Havířov, Prague, Uherské Hradiště, Znojmo
2025-07-22
Recruiting
AbbVie
Phase 2
180
Hlučín, Uherské Hradiště, Zlín
2025-06-20
Active, closed
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
NCT07000136Heterozygous Familial Hypercholesterolaemia
DrugAZD0780
AstraZeneca
Phase 3
473
Hradec Králové, Prague, Uherské Hradiště
2025-06-10
Active, closed
Eli Lilly and Company
Phase 3
600
České Budějovice, Český Krumlov, Ostrava, Prague, Uherské Hradiště
2025-05-19
Active, closed
Eli Lilly and Company
Phase 3
800
České Budějovice, Český Krumlov, Ostrava, Prague, Uherské Hradiště
2025-05-15
Active, closed
Eli Lilly and Company
Phase 3
1,400
České Budějovice, Český Krumlov, Ostrava, Prague, Uherské Hradiště
2025-05-15
Recruiting
AbbVie
Phase 2
300
Brno, Hlučín, Uherské Hradiště, Zlín
2025-04-11
Recruiting
Takeda
Phase 3
1,088
Brno, Hlučín, Prague, Uherské Hradiště, Ostrava, Zlín, Pardubice
2025-03-03
Active, closed
Janssen Research & Development, LLC
Phase 3
552
Brno, Brno-Židenice, Břeclav, Hlučín, Karvina Frystat, Ostrava, Prague, Uherské Hradiště
2025-02-21
Active, closed
Immunovant Sciences GmbH
Phase 2
120
Brno, Ostrava, Praha 2 Nove Mesto, Uherské Hradiště, Zlín
2025-01-10
Active, closed
Janssen Research & Development, LLC
Phase 3
813
Brno, Břeclav, Hlučín, Ostrava, Prague, Uherské Hradiště, Zlín
2025-01-09
Active, closed
Janssen Research & Development, LLC
Phase 3
655
Brno, Karvina Frystat, Ostrava, Prague, Uherské Hradiště
2024-12-04
Active, closed
Novartis Pharmaceuticals
Phase 2
155
Brno, Prague, Uherské Hradiště
2024-07-02
Active, closed
Novartis Pharmaceuticals
Phase 3
162
Prague, Brno, Hlučín, Uherské Hradiště
2024-06-28
Recruiting
Novartis Pharmaceuticals
Phase 3
550
Brno, Prague, Uherské Hradiště
2024-05-21
Active, closed
Novartis Pharmaceuticals
Phase 3
612
Brno, Uherské Hradiště
2023-10-27
Active, closed
Alfasigma S.p.A.
Phase 3
495
Prague, Brno, Ostrava, Pardubice, Uherské Hradiště, Zlín
2023-04-05
Active, closed
Novartis Pharmaceuticals
Phase 4
240
Prague, Uherské Hradiště
2023-03-28
Active, closed
Novartis Pharmaceuticals
Phase 3
436
Brno, Prague, Uherské Hradiště
2023-03-02
Active, closed
Janssen Research & Development, LLC
Phase 4
411
Brno, Brno-Židenice, Hlučín, Karvina Frystat, Ostrava, Pardubice, Prague, Uherské Hradiště
2021-08-30
Active, closed
Bristol-Myers Squibb
Phase 3
729
Brno, Ostrava, Prague, Uherské Hradiště
2021-07-15
Active, closed
Bristol-Myers Squibb
Phase 3
670
Prague, Uherské Hradiště, Zlín, Ostrava, Pardubice
2021-07-13
Active, closed
Janssen Research & Development, LLC
Phase 3
1,054
Brno, Brno-Židenice, Hlučín, Ostrava, Pardubice, Prague, Uherské Hradiště, Zlín
2021-06-17
Recruiting
Secukinumab Open Label Roll-over Extension Protocol
NCT04638647Autoimmunity, Inflammation
DrugSecukinumab
Novartis Pharmaceuticals
Phase 4
1,000
Ostrava, Brno-Zidonice, Brno, Hradec Králové, Prague, Uherské Hradiště
2020-12-22
Active, closed
AbbVie
Phase 3
964
Brno, Prague, Uherské Hradiště
2019-03-25
Active, closed
Janssen Research & Development, LLC
Phase 3
765
Hradec Králove, Liberec, Olomouc, Pardubice, Pilsen, Prague, Uherské Hradiště
2019-01-25
Rows per page Showing 1–38 of 38
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Czech investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-czechia/city/uhersk-hradi-t

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Czechia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,513 studies in total at the last sync on 11 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 38 of those studies with a site in Uherské Hradiště.

How many clinical trials are recruiting in Uherské Hradiště?

16 of the 38 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 22 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Uherské Hradiště), 38 studies
PhaseStudiesRecruitingShare
Phase 3271171.1%
Phase 27318.4%
Phase 4317.9%
Phase 1112.6%

Most active sponsors

Lead sponsors with the most studies (Uherské Hradiště)
Lead sponsorStudiesRecruiting
Janssen Research & Development, LLC70
Novartis Pharmaceuticals72
Eli Lilly and Company63
AbbVie32
Ascletis Pharma (China) Co., Limited22
Bristol-Myers Squibb20
Takeda22
Alfasigma S.p.A.10
AstraZeneca10
Boehringer Ingelheim11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.